Vilket är priset för Merck & Co., Inc. (MRK)

Priset för Merck & Co., Inc. (MRK) är $115.67

Vilket är marknadsvärdet för Merck & Co., Inc. (MRK)

Marknadsvärdet för Merck & Co., Inc. (MRK) är $285.98B

Merck & Co., Inc. (MRK) Utestående Aktier

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

År	Utestående aktier	Ändra
2026 (TTM)	2.49B	-0.70%
2025	2.51B	-0.97%
2024	2.53B	-2.88%
2023	2.61B	2.97%
2022	2.53B	0.08%
2021	2.53B	0.00%
2020	2.53B	-1.36%
2019	2.57B	-1.06%
2018	2.59B	-3.86%
2017	2.70B	-1.90%
2016	2.75B	-1.16%
2015	2.78B	-2.01%
2014	2.84B	-3.05%
2013	2.93B	-3.27%
2012	3.03B	-0.47%
2011	3.04B	-1.75%
2010	3.10B	46.79%
2009	2.11B	-1.29%
2008	2.14B	-1.59%
2007	2.17B	-0.33%
2006	2.18B	-0.88%
2005	2.20B	-0.99%
2004	2.22B	-0.79%
2003	2.24B	-0.92%
2002	2.26B	-1.35%
2001	2.29B	-0.81%
2000	2.31B	0.00%

År

Utestående aktier

Ändra

2026 (TTM)

2.49B

-0.70%

2025

2.51B

-0.97%

2024

2.53B

-2.88%

2023

2.61B

2.97%

2022

2.53B

0.08%

2021

2.53B

0.00%

2020

2.53B

-1.36%

2019

2.57B

-1.06%

2018

2.59B

-3.86%

2017

2.70B

-1.90%

2016

2.75B

-1.16%

2015

2.78B

-2.01%

2014

2.84B

-3.05%

2013

2.93B

-3.27%

2012

3.03B

-0.47%

2011

3.04B

-1.75%

2010

3.10B

46.79%

2009

2.11B

-1.29%

2008

2.14B

-1.59%

2007

2.17B

-0.33%

2006

2.18B

-0.88%

2005

2.20B

-0.99%

2004

2.22B

-0.79%

2003

2.24B

-0.92%

2002

2.26B

-1.35%

2001

2.29B

-0.81%

2000

2.31B

0.00%

Företag	Utestående aktier	Skillnad	Land
Eli Lilly LLY.US	898.00M	-63.93%	US
AstraZeneca PLC AZN.US	3.10B	24.50%	GB
Johnson & Johnson JNJ.US	2.43B	-2.46%	US
AbbVie Inc. ABBV.US	1.78B	-28.50%	US
Novartis AG NVS.US	1.91B	-23.17%	CH

Företag

Utestående aktier

Skillnad

Land